Edmond De Rothschild Holding S.A. Nuvectis Pharma, Inc. Transaction History
Edmond De Rothschild Holding S.A.
- $5.72 Billion
- Q2 2024
A detailed history of Edmond De Rothschild Holding S.A. transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, Edmond De Rothschild Holding S.A. holds 19,170 shares of NVCT stock, worth $124,605. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,170
Previous 19,170
-0.0%
Holding current value
$124,605
Previous $157,000
22.93%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NVCT
# of Institutions
41Shares Held
1.77MCall Options Held
0Put Options Held
0-
Ronit Capital LLP563KShares$3.66 Million5.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA251KShares$1.63 Million0.0% of portfolio
-
Baldwin Brothers LLC169KShares$1.1 Million0.08% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny119KShares$776,4830.0% of portfolio
-
Black Rock Inc. New York, NY83.4KShares$542,1780.0% of portfolio
About Nuvectis Pharma, Inc.
- Ticker NVCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,642,500
- Market Cap $95.2M
- Description
- Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...